Chinese english Germany Japanese Korea

Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1)

Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) Struktur
CAS-Nr.
Englisch Name:
Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1)
Synonyma:
Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1)
CBNumber:
CB05785300
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file
Request For Quotation

Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) Eigenschaften

Sicherheit

Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) Chemische Eigenschaften,Einsatz,Produktion Methoden

Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Zeye Biotechnology Co., Ltd. 021-61998551 13122364865
 sale1@shzysw.net China 9772 58
Shanghai Bolsen Biotechnology Co., LTD 021-67681877 13166061152
 bioesn@163.com China 7373 58
  • Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1)
Copyright 2019 © ChemicalBook. All rights reserved